News | November 01, 2011

Corindus Hosts Presentation on Robotic-Assisted PCI at TCT 2011

November 1, 2011 – Corindus Vascular Robotics said leading experts in interventional cardiology will speak about their clinical experience using the CorPath 200 System at a symposium co-sponsored by Corindus Vascular Robotics and Philips Healthcare. The event, entitled "Robotic-Assisted PCI, User Experience in Daily Practice," will take place at 7 a.m Thursday, Nov. 10, 2011 at the Moscone Center, Room 112 at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.

Moderated by Peter J. Fitzgerald, M.D., and Joseph P. Carrozza Jr., M.D., the symposium will include presentations on the benefits robotic-assisted percutaneous coronary intervention (PCI) procedures, followed by roundtable discussion. Presentations include:

• "How Cardiovascular Robotics is changing PCI," Jeffrey W. Moses, M.D.

• "Overview of the CorPath 200 System and the PRECISE Trial," Giora Weisz, M.D.

• "High-Volume Operator Experience with Robotic-Assisted PCI," D. Christopher Metzger, M.D.

• "Integrating the CorPath 200 System into the Cath Lab Workflow," Ronald Caputo, M.D.

• "Beyond PCI - Robotics for Structural Heart Disease Procedures," Peter J. Fitzgerald, M.D.

"As the current practice of interventional cardiology evolves into more complex procedures, there is a need for improved safety and efficiency in the catheterization laboratory," said Carrozza, chief of cardiovascular medicine at St. Elizabeth's Medical Center, Boston, Mass. "The CorPath 200 System has the potential to improve the standard-of-care for PCI as well as future applications such as structural heart, peripheral and neurology procedures."

According to recent data published in the Catheterization and Cardiovascular Intervention journal, an interventional cardiologist's daily exposure to radiation and the physical stresses inherent in the cath lab can lead to occupational health risks including orthopedic problems, cataracts and cancer. The CorPath 200 System allows for controlled robotic-assisted placement of coronary guidewires and stent/balloon catheters from an ergonomically optimized interventional cockpit. The lead-lined cockpit protects the operator from radiation exposure. The comfortable seated position in front of the "slaved" monitors provides enhanced visualization of the angiography screen while reducing fatigue and minimizes head, neck and back strain.

"When introducing new technology into the cath lab, simplicity is best. The CorPath System is easy to use and fits nicely into the lab with minimum learning curve for the staff and me," said Ron Caputo, M.D., FACC, FSCAI, director of cardiac services and cardiology research at St. Joseph's Hospital Health Center in Syracuse, N.Y. "The joysticks are positioned in front of monitors, allowing me to focus on the patient's physiology, while the lead lined cockpit allows me to safely perform PCI procedures without wearing a heavy lead apron."

Corindus Vascular Robotic activities at TCT 2011 include:

• Giora Weisz, M.D., will host a discussion: "Corindus Robotic-Assisted Angioplasty: Current Status and Distant Vision" at 1:22 p.m. Monday, Nov. 7, 2011, in room 134.

• Corindus Vascular Robotics will host hands-on demonstrations of the CorPath 200 System CorPath 200 system hands-on demonstration at TCT exhibit hall booth 2209. To reserve your booth presentation of the CorPath 200 System, please call 508.653.3335 x200 or e-mail [email protected].

• On Thursday, Nov.. 10, Corindus and Philips Healthcare will host the CorPath Symposium. To register for the breakfast symposium, please visit:

For more information:

NOTE: The CorPath 200 System is an investigational device and limited by federal law to investigational use only.



Related Content

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init